Ohata Hiroshi, Oka Masashi, Yanaoka Kimihiko, Shimizu Yasuhito, Mukoubayashi Chizu, Mugitani Kouichi, Iwane Masataka, Nakamura Hideya, Tamai Hideyuki, Arii Kenji, Nakata Hiroya, Yoshimura Noriko, Takeshita Tetsuya, Miki Kazumasa, Mohara Osamu, Ichinose Masao
Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama-city, Wakayama 641-0012, Japan.
Cancer Sci. 2005 Oct;96(10):713-20. doi: 10.1111/j.1349-7006.2005.00098.x.
With the aim of developing more efficient gastric cancer screening programs for use in Japan, we studied a new screening program that combines serum pepsinogen (PG) testing and barium digital radiography (DR). A total of 17 647 middle-aged male subjects underwent workplace screening over a 7-year period using a combination of PG testing and DR. This program's effectiveness, as well as other characteristics of the program, was analyzed. Forty-nine cases of gastric cancer were detected (comprising 88% early cancer cases). The detection rate was 0.28%, and the positive predictive value was 0.85%. The PG test detected 63.3% of cases, DR detected 69.4% of cases, and both tests were positive in 32.7% of cancer cases. The two methods were almost equally effective, and were considerably more effective than conventional screening using photofluorography. Each screening method detected a distinct gastric cancer subgroup; the PG test efficiently detected asymptomatic small early cancer with intestinal type histology, while DR was efficient at detecting cancers with depressed or ulcerated morphology and diffuse type histology. The cost for the detection of a single cancer was much less than that for conventional screening. In fact, it is possible to further reduce the cost of detecting a single cancer to a cost comparable to that of surgically resecting a single gastric cancer. Thus, it is probable that a highly efficient gastric cancer screening system can be implemented by combining the two screening methods. Such a screening program would be beneficial in a population at high risk for gastric cancer.
为了开发更高效的用于日本的胃癌筛查项目,我们研究了一种结合血清胃蛋白酶原(PG)检测和数字钡剂造影(DR)的新筛查项目。在7年期间,共有17647名中年男性受试者接受了工作场所的PG检测和DR联合筛查。分析了该项目的有效性以及其他特点。共检测出49例胃癌(其中88%为早期癌症病例)。检出率为0.28%,阳性预测值为0.85%。PG检测出63.3%的病例,DR检测出69.4%的病例,两种检测均为阳性的癌症病例占32.7%。这两种方法几乎同样有效,并且比传统的荧光摄影筛查有效得多。每种筛查方法检测出不同的胃癌亚组;PG检测有效地检测出无症状的小早期肠型组织学癌症,而DR则有效地检测出形态为凹陷或溃疡型以及弥漫型组织学的癌症。检测一例癌症的成本远低于传统筛查。事实上,有可能将检测一例癌症的成本进一步降低到与手术切除一例胃癌相当的成本。因此,通过结合这两种筛查方法有可能实施一种高效的胃癌筛查系统。这样的筛查项目对胃癌高危人群将是有益的。